Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Orion Market Research Pvt Ltd | PRODUCT CODE: 1064634

Cover Image

PUBLISHER: Orion Market Research Pvt Ltd | PRODUCT CODE: 1064634

Global Acromegaly Drugs Market 2021-2027

PUBLISHED:
PAGES: 110 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5125
Unprintable PDF (5 User License)
USD 6625
Printable PDF (Corporate License)
USD 8280

Add to Cart

Global Acromegaly Drug Market Size, Share & Trends Analysis Report by Product Type (Somatostatin Analogs, Growth Hormone Receptor Antagonist (GHRA), Dopamine Agonists, and Other Product Types), Forecast Period (2021-2027)

The global acromegaly drug market is anticipated to grow at a considerable CAGR during the forecast period. Acromegaly is a hormonal condition that occurs when the pituitary gland produces too much growth hormone in maturity. According to the National Institutes of Health (NIH) and Endocrine Society, around 69,000 individuals living with acromegaly globally. In addition, increasing incidence of pituitary tumors and acromegaly, changing lifestyle and increasing investments in R&D for developing new molecules are driving the growth of acromegaly drugs market.

The global acromegaly drugs market is segmented based on product type into somatostatin analogs, growth hormone receptor antagonist (GHRA), dopamine agonists, and other product types. Somatostatin analogs segment is estimated to hold a prominent share in the acromegaly drugs market and is anticipated to show a similar trend during the forecast period owing to the wide availability of drugs and its cost-efficiency.

Geographically, the global acromegaly drugs market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World.

Market Segmentation

1. Global Acromegaly Drugs Market Research and Analysis by Product Type

The Report Covers

  • Comprehensive research methodology of the global acromegaly drugs market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global acromegaly drugs market.
  • Insights about market determinants that are stimulating the global acromegaly drugs market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Product Code: OMR2024112

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Conclusion

3. Market Determinants

  • 3.1. Motivators
  • 3.2. Restraints
  • 3.3. Opportunities

4. Market Segmentation

  • 4.1. Global Acromegaly Drug Market by Product Type
    • 4.1.1. Somatostatin Analogs
    • 4.1.2. Growth Hormone Receptor Antagonist (GHRA)
    • 4.1.3. Dopamine Agonists
    • 4.1.4. Other Product Types

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Chiasma Inc.
  • 6.2. Ionis Pharmaceuticals Inc.
  • 6.3. Ipsen
  • 6.4. Novartis AG
  • 6.5. Pfizer Inc
  • 6.6. Validus Pharmaceuticals LLC
Product Code: OMR2024112

LIST OF TABLES

  • 1. GLOBAL ACROMEGALY DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
  • 2. GLOBAL ACROMEGALY SOMATOSTATIN ANALOGS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL ACROMEGALY GROWTH HORMONE RECEPTOR ANTAGONIST (GHRA) MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL ACROMEGALY DOPAMINE AGONISTS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 5. GLOBAL OTHER ACROMEGALY PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL ACROMEGALY DRUG MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
  • 7. NORTH AMERICAN ACROMEGALY DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 8. NORTH AMERICAN ACROMEGALY DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
  • 9. EUROPEAN ACROMEGALY DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 10. EUROPEAN ACROMEGALY DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
  • 11. ASIA-PACIFIC ACROMEGALY DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 12. ASIA-PACIFIC ACROMEGALY DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)
  • 13. REST OF THE WORLD ACROMEGALY DRUG MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ACROMEGALY DRUG MARKET SHARE BY PRODUCT TYPE, 2020 VS 2027 (%)
  • 2. GLOBAL ACROMEGALY DRUG MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 3. US ACROMEGALY DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 4. CANADA ACROMEGALY DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 5. UK ACROMEGALY DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 6. FRANCE ACROMEGALY DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 7. GERMANY ACROMEGALY DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 8. ITALY ACROMEGALY DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 9. SPAIN ACROMEGALY DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 10. REST OF EUROPE ACROMEGALY DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 11. INDIA ACROMEGALY DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 12. CHINA ACROMEGALY DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 13. JAPAN ACROMEGALY DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 14. REST OF ASIA-PACIFIC ACROMEGALY DRUG MARKET SIZE, 2020-2027 ($ MILLION)
  • 15. REST OF THE WORLD ACROMEGALY DRUG MARKET SIZE, 2020-2027 ($ MILLION)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!